These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 35941638)

  • 61. Identification of a Novel Ferroptosis-Related Gene Prediction Model for Clinical Prognosis and Immunotherapy of Colorectal Cancer.
    Yang YB; Zhou JX; Qiu SH; He JS; Pan JH; Pan YL
    Dis Markers; 2021; 2021():4846683. PubMed ID: 34868393
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Identification of an immune-related gene-based signature to predict prognosis of patients with gastric cancer.
    Qiu XT; Song YC; Liu J; Wang ZM; Niu X; He J
    World J Gastrointest Oncol; 2020 Aug; 12(8):857-876. PubMed ID: 32879664
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Identification and Validation of a Six Immune-Related Genes Signature for Predicting Prognosis in Patients With Stage II Colorectal Cancer.
    Li X; Xie M; Yin S; Xiong Z; Mao C; Zhang F; Chen H; Jin L; Lan P; Lian L
    Front Genet; 2021; 12():666003. PubMed ID: 34017356
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A signature based on 11 autophagy genes for prognosis prediction of colorectal cancer.
    Chen S; Wang Y; Wang B; Zhang L; Su Y; Xu M; Zhang M
    PLoS One; 2021; 16(10):e0258741. PubMed ID: 34699544
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Prognostic Model of Colorectal Cancer Constructed by Eight Immune-Related Genes.
    Wen S; He L; Zhong Z; Mi H; Liu F
    Front Mol Biosci; 2020; 7():604252. PubMed ID: 33330631
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Development of prognostic signature based on immune-related genes in muscle-invasive bladder cancer: bioinformatics analysis of TCGA database.
    Jin K; Qiu S; Jin D; Zhou X; Zheng X; Li J; Liao X; Yang L; Wei Q
    Aging (Albany NY); 2021 Jan; 13(2):1859-1871. PubMed ID: 33465047
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Identification and Validation of Immune-Related Gene Prognostic Signature for Hepatocellular Carcinoma.
    Chen W; Ou M; Tang D; Dai Y; Du W
    J Immunol Res; 2020; 2020():5494858. PubMed ID: 32211443
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Immune-related gene-based prognostic index for predicting survival and immunotherapy outcomes in colorectal carcinoma.
    Liang Z; Sun R; Tu P; Liang Y; Liang L; Liu F; Bian Y; Yin G; Zhao F; Jiang M; Gu J; Tang D
    Front Immunol; 2022; 13():944286. PubMed ID: 36591255
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Development and Validation of a Clinical Prognostic Model Based on Immune-Related Genes Expressed in Clear Cell Renal Cell Carcinoma.
    Ren S; Wang W; Shen H; Zhang C; Hao H; Sun M; Wang Y; Zhang X; Lu B; Chen C; Wang Z
    Front Oncol; 2020; 10():1496. PubMed ID: 32983989
    [No Abstract]   [Full Text] [Related]  

  • 70. SPOCK1 and POSTN are valuable prognostic biomarkers and correlate with tumor immune infiltrates in colorectal cancer.
    Gan C; Li M; Lu Y; Peng G; Li W; Wang H; Peng Y; Hu Q; Wei W; Wang F; Liu L; Zhao Q
    BMC Gastroenterol; 2023 Jan; 23(1):4. PubMed ID: 36611136
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Construction of a Prognostic Immune Signature for Squamous-Cell Lung Cancer to Predict Survival.
    Chen RL; Zhou JX; Cao Y; Sun LL; Su S; Deng XJ; Lin JT; Xiao ZW; Chen ZZ; Wang SY; Lin LZ
    Front Immunol; 2020; 11():1933. PubMed ID: 33072067
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A New Inflammation-Related Risk Model for Predicting Hepatocellular Carcinoma Prognosis.
    Xing M; Li J
    Biomed Res Int; 2022; 2022():5396128. PubMed ID: 35572724
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Identification of a novel immune signature for optimizing prognosis and treatment prediction in colorectal cancer.
    Li Y; Li Y; Xia Z; Zhang D; Chen X; Wang X; Liao J; Yi W; Chen J
    Aging (Albany NY); 2021 Dec; 13(23):25518-25549. PubMed ID: 34898475
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Exploration of prognostic index based on immune-related genes in patients with liver hepatocellular carcinoma.
    Shi W; Feng L; Dong S; Ning Z; Hua Y; Liu L; Chen Z; Meng Z
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32579175
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The prognostic value of an immune-related gene signature and infiltrating tumor immune cells based on bioinformatics analysis in primary esophageal cancer.
    Du H; Pang S; Li Y; Zhu L; Hang J; Chen L
    J Gastrointest Oncol; 2022 Aug; 13(4):1556-1570. PubMed ID: 36092327
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Development and validation of a novel immune-related prognostic model in lung squamous cell carcinoma.
    Liu Z; Wan Y; Qiu Y; Qi X; Yang M; Huang J; Zhang Q
    Int J Med Sci; 2020; 17(10):1393-1405. PubMed ID: 32624696
    [No Abstract]   [Full Text] [Related]  

  • 77. Exploring the potential mechanisms of Yi-Yi-Fu-Zi-Bai-Jiang-San therapy on the immune-inflamed phenotype of colorectal cancer via combined network pharmacology and bioinformatics analyses.
    Liu Y; Liang Y; Su Y; Hu J; Sun J; Zheng M; Huang Z
    Comput Biol Med; 2023 Nov; 166():107432. PubMed ID: 37729701
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Tumor microenvironment-related gene selenium-binding protein 1 (SELENBP1) is associated with immunotherapy efficacy and survival in colorectal cancer.
    Zhu C; Wang S; Du Y; Dai Y; Huai Q; Li X; Du Y; Dai H; Yuan W; Yin S; Wang H
    BMC Gastroenterol; 2022 Oct; 22(1):437. PubMed ID: 36253721
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Construction of an immune predictive model and identification of TRIP6 as a prognostic marker and therapeutic target of CRC by integration of single-cell and bulk RNA-seq data.
    Liu W; Luo X; Zhang Z; Chen Y; Dai Y; Deng J; Yang C; Liu H
    Cancer Immunol Immunother; 2024 Mar; 73(4):69. PubMed ID: 38430268
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Identification and validation of a novel signature as a diagnostic and prognostic biomarker in colorectal cancer.
    Wang D; Liufu J; Yang Q; Dai S; Wang J; Xie B
    Biol Direct; 2022 Nov; 17(1):29. PubMed ID: 36319976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.